A. Dhadda

发表

Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer.

A. Zaitoun, E. Bessell, A. Dhadda, 2011, European journal of cancer.

Regression of rectal cancer with radiotherapy with or without concurrent capecitabine--optimising the timing of surgical resection.

A. Zaitoun, E. Bessell, A. Dhadda, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

A multi-centre analysis of adjuvant contact x-ray brachytherapy (CXB) in rectal cancer patients treated with local excision - preliminary results of the CONTEM1 study.

I. Hunter, J. Gérard, A. Sun Myint, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Organ Preservation Using Contact Radiotherapy for Early Rectal Cancer: Outcomes of Patients Treated at a Single Centre in the UK.

S. Killeen, I. Hunter, A. Martín, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

A. Briggs, T. Hickish, J. Tabernero, 2018, British Journal of Cancer.

A Cost-Effectiveness Analysis of Contact X-ray Brachytherapy for the Treatment of Patients with Rectal Cancer Following a Partial Response to Chemoradiotherapy.

T. Athanasiou, B. Collins, A. Martin, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Updated results of the SCOT study : An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for colorectal cancer

J. Tabernero, B. Glimelius, A. Haydon, 2017 .

The Role of Contact X-Ray Brachytherapy in Early Rectal Cancer – Who, when and How?

T. Rockall, D. Pritchard, J. Gérard, 2022, Clinical Oncology.

Impact of neutropenia on delivering planned chemotherapy for solid tumours.

S. Sundar, A. Dhadda, D. Fyfe, 2007, European journal of cancer care.

Prognosis of patients with triple-negative breast cancer and brain metastasis.

S. Upadhyay, R. Venkitaraman, A. Dhadda, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Bilateral avascular necrosis of the hips after chemoradiotherapy for cervical cancer.

A. Dhadda, S. Chan, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

Paraneoplastic hypercalcaemia in squamous cell carcinoma of the anus: first reported case.

M. Teo, A. Dhadda, J. Gunn, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

External beam radiotherapy for extensive genital condyloma acuminate: a role in selected patients?

A. Dhadda, A. Anand, S. Chan, 2008, Clinics in oncology.

Single fraction radiotherapy for small superficial carcinoma of the skin.

S. Chan, R. Swindell, R Swindell, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

A. Briggs, T. Hickish, J. Tabernero, 2018, The Lancet. Oncology.

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial.

R. Schiappa, L. Mineur, J. Gérard, 2023, The lancet. Gastroenterology & hepatology.

Fatal herpes simplex virus hepatitis following neoadjuvant chemoradiotherapy and anterior resection for rectal cancer.

J. Hartley, J. Cooke, A. Dhadda, 2014, Annals of the Royal College of Surgeons of England.

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.

A. Briggs, T. Hickish, J. Tabernero, 2019, Health technology assessment.

Treatment: the role of contact X‐ray brachytherapy (Papillon) in the management of early rectal cancer

A. Stewart, A. Sun Myint, A. Dhadda, 2019, Colorectal Disease.

Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy.

J. Scholefield, A. Zaitoun, E. Bessell, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Contact x-ray brachytherapy (Papillon) in addition to chemoradiotherapy to improve organ preservation in early cT2-T3 rectal adenocarcinoma: The 3-year results of OPERA randomized trial (NCT02505750).

N. Magné, L. Mineur, J. Gérard, 2022, Journal of Clinical Oncology.

Final DFS results of the SCOT study: An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for colorectal cancer.

J. Tabernero, B. Glimelius, A. Haydon, 2017 .

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

C. Caldas, E. Provenzano, J. Abraham, 2019, The Lancet.

Toxicity and quality of life data from SCOT: An international phase III randomized (1:1) noninferiority trial comparing 3 vs 6 months of oxaliplatin-based adjuvant chemotherapy.

A. Briggs, J. Tabernero, B. Glimelius, 2015 .

Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis

T. Rockall, J. Folkesson, C. Jordan, 2023, Clinical and translational radiation oncology.

ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

P. Quirke, S. Bach, R. Glynne-Jones, 2020 .

Organ Preservation Using Contact Radiotherapy for Early Rectal Cancer: Outcomes of Patients Treated at a Single Centre in the UK.

S. Killeen, I. Hunter, A. Dhadda, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

A Cost-Effectiveness Analysis of Contact X-ray Brachytherapy for the Treatment of Patients with Rectal Cancer Following a Partial Response to Chemoradiotherapy.

T. Athanasiou, B. Collins, A. Martin, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Number of lymph nodes recovered as an independent prognostic factor in predicting outcome in patients with pathologically node-negative rectal cancer following preoperative chemo/radiotherapy.

A. Zaitoun, E. Bessell, A. Dhadda, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Re: Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery

J. Gérard, A. Sun Myint, A. Dhadda, 2018, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.